Precision Medicine and Cancer
ASCO’s Annual Meeting is showcasing new research on precision medicine. See how this new approach is transforming the way we treat cancer.... Learn More
Opdivo (nivolumab) the Immunotherapy Cancer Treatment
Opdivo (nivolumab) is an FDA approved immunotherapy cancer drug treatment that is showing great promise for treating various types of cancer, including... Learn More
Harnessing the Science of Immuno-oncology at Novartis
Our immuno-oncology researchers are rapidly making discoveries about how cancers trip up our immune systems. Potential medicines that we’re developing aim put... Learn More
About Opdivo the Immunotherapy Cancer Treatment
Developed by Bristol-Myers Squipp, Opdivo (nivolumab) is an FDA approved immunotherapy cancer drug treatment that is showing great promise for treating various... Learn More
Chemo Rock
See what happens when a group of patients take on ‘cancer’ together. Learn more about the video at www.oacancer.com/chemorock